According to Coherent Market Insights, Global Cancer supportive care products Market is estimated to be valued at US$ 32,458.0 million in 2023 and is expected
David R. Penberthy, MD, MBA, 2022-2023 Association of Community Cancer Centers president, addresses technological advancements made during his presidency and how community oncology is working to ensure gains in health equity continue moving forward.
Connections: Crystal Bridges hires Horn for PR role - Talk Business & Politics talkbusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkbusiness.net Daily Mail and Mail on Sunday newspapers.
Stacey A. Cohen, MD, discusses the advantages and limitations of ctDNA as a biomarker for detecting minimal residual disease , real-world data on the relationship between fluctuating cfDNA levels and ctDNA detection, and how implementing ctDNA testing earlier to identify minimal residual disease could serve as a prognostic tool in clinical practice.